Before deciding to move forward with Web-Enabled EDC, I would
like to share an article about a famous corporation that failed to see the
future’s technology.
Quotes
from the article:
-
Kodak
did not fail because it missed the digital age. It actually invented the first
digital camera in 1975. However, instead of marketing the new technology, the
company held back for fear of hurting its lucrative film business, even after
digital products were reshaping the market.
-
Unfortunately,
the company had the nearsighted view that it was in the film business instead
of the story telling business, and it believed that it could protect its
massive share of market with its marketing. Kodak thought that its new digital
technology would cannibalize its film business. Sony
and Canon saw an opening and charged ahead with
their digital cameras. When Kodak decided to get in the game it was too late.
The company saw its market share decline, as digital imaging became dominant.
-
This
blind faith in marketing’s ability to overcome the threat from the new
technology proved fatal. Kodak failed to adapt to a new marketplace and new
consumer attitudes.
Even though the Kodak situation is not 100% related to
P&G’s Case study, it shows the long-term benefits that P&G may gain
from the Web-Enabled EDC. D’Alonzo feels confident about recommending a shift
toward the technology as the default standard for the company’s future trials based
on the results of the pilot trials and his own knowledge of how Web-enabled EDC
speeds up the process of trial management. Although D’Alonzo is worried about
other pharmaceutical companies’ slowness in adopting the Web-enabled EDC, he
still feels correct about EDC.
I believe that D’Alonzo is correct. Even though the costs
and benefits of the technology Web-enabled EDC is uncertain, I believe that this
technology would benefit P&G in long term, or at least, it will put them on
a higher standard compared to other pharmaceutical companies.
No comments:
Post a Comment